BMS’ Opdivo/Yervoy combo cleared for kidney cancer

17th April 2018 Uncategorised 0

US regulators have approved a combination of Bristol-Myers Squibb’s immunotherapy drugs Opdivo and Yervoy as a first-line treatment for patients with advanced renal cell carcinoma.

More: BMS’ Opdivo/Yervoy combo cleared for kidney cancer
Source: News